These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6609265)

  • 1. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ; Buurman WA; van der Linden CJ
    J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD; Castellazzi M; Buttin G
    J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
    Carson DA; Seegmiller JE
    J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
    Martín M; Huguet J; Centelles JJ; Franco R
    J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azacytidine-induced reactivation of adenosine deaminase in a murine cytotoxic T cell line.
    Castellazzi M; Vielh P; Longacre S
    Eur J Immunol; 1986 Sep; 16(9):1081-6. PubMed ID: 2428625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between adenosine deaminase and a human thymus leukemia antigen isolated from MOLT 4 cells.
    Dowell BL; Segars JH; Metzgar RS
    Cancer Res; 1981 Jan; 41(1):343-5. PubMed ID: 7192600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adenosine deaminase in lymphocyte proliferation.
    Hovi T; Smyth JF; Allison AC; Williams SC
    Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to a selection system for adenosine-deaminase-positive (ADA+) cells and detection of rat ADA+ "revertants".
    Hirschhorn R; Ellenbogen A; Martiniuk F
    J Cell Physiol; 1985 May; 123(2):277-82. PubMed ID: 3872305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
    J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the relationship between adenosine deaminase and immune function.
    Burridge PW; Paetkau V; Henderson JF
    J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
    Checkik BE; Perets A; SenGupta S; Fernandes B
    J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of adenosine deaminase among lymphocyte populations in the rat.
    Barton R; Martiniuk F; Hirschhorn R; Goldschneider I
    J Immunol; 1979 Jan; 122(1):216-20. PubMed ID: 310828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
    Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
    J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
    J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine-resistant Chinese hamster fibroblast variants with hyperactive adenosine-deaminase: an analysis of the protection against exogenous adenosine afforded by increased activity of the deamination pathway.
    Fernandez-Mejia C; Debatisse M; Buttin G
    J Cell Physiol; 1984 Sep; 120(3):321-8. PubMed ID: 6205001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.